Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alexandra Cann
Observed names:
A Cann,
A. Cann,
Cann, Alexandra
Institution:
Imperial College Healthcare NHS Trust
Observed institutions:
Imperial College Healthcare NHS Trust,
NIHR Imperial Biomedical Research Centre,
Imperial College London
ORCID:
0000-0002-7410-8407
Observed ORCID:
0000-0002-7410-8407
OpenAlex ID:
A5041321715
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
425
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
383
Population antibody responses following COVID-19 vaccination in 212,102 individuals
2022
·
Helen Ward
, Matthew Whitaker
, et al.
·
Nature Communications
·
178
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
156
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
48
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
42
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
15
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
RECOVERY Collaborative Group
, Peter Sandercock
, et al.
·
Nature Communications
·
13
PDF
Changing patterns of clinical presentation of COVID-19 in hospital admissions: With, or because of, COVID?
2022
·
H Rafferty
, A Cann
, et al.
·
Journal of Infection
·
13
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
9
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study
2021
·
Alexandra Cann
, Candice Clarke
, et al.
·
Wellcome Open Research
·
7
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
6
PDF
Time to unshackle the medical treatment of obesity in the NHS
2024
·
Saleem Ansari
, Tina Mazaheri
, et al.
·
Clinical Medicine
·
4
Replication Data for: SARS-CoV-2 Antibody Lateral Flow Assay for Possible Use in Seroprevalence Surveys: a Diagnostic Accuracy Study
2021
·
Cann, Alexandra
·
Harvard Dataverse
·
1
Show more works
View as search
Works count:
14
Citation count:
1,300
H-index:
9
I10-index:
9
Year
Topic
Type